I disagree with the premise that “patient centricity” is the key for clinical trial optimisation.
Clinical trials involve multiple stakeholder groups, each with their own objectives and interests. Like any system, optimum performance depends on alignment and interaction between parties.
Focusing on any one party as the central focus, may seem beneficial at first glance, but is ultimately self limiting. Why grease only one cog?
A more powerful approach is stakeholder collaboration and alignment around three guiding principles:
A shared objective:
Regardless which area of the clinical trial process we operate, we all need to take accountability for promoting and affirming the fact that our shared objective is to advance human health. We all have unique roles to play with their own challenges; however we need to remember we are all part of a big team pulling and pushing in the same direction. Of course this is also true patient centricity.
Innovation and Flexibility:
The clinical trial landscape is constantly evolving. A commitment to exploring innovative approaches, and new ways of doing things, is critical to our success. I don’t just mean focusing on the latest trends like adaptive trial designs, DCT or AI. Instead adopting and fundamental commitment to doing the simple things in a better way. This means continuously seeking out efficiencies, streamlining processes, and eliminating unnecessary burdens for all stakeholders. By constantly questioning the status quo and embracing a culture of continuous improvement, we can optimise the entire clinical trial process.
Transparency and Trust:
Open communication and clear expectations throughout the trial process build trust and foster a collaborative environment. Regular updates, transparent reporting of progress and challenges, and ensuring all stakeholders are informed and involved in decision-making processes are crucial. Transparency helps mitigate misunderstandings, aligns everyone’s efforts toward the common goal, and creates a sense of shared responsibility and trust among all parties.
If we all commit to focusing on these three principles it will allow us to make real, sustainable progress…together.
Outsourcing in Clinical Trials Event Series
#clinicaltrials #health #clinicalresearch #biotech
➡ Clinical trial optimisation starts with the patient at the centre
At the 15th Annual Outsourcing in Clinical Trials East Coast conference held on 21 – 22 May in King of Prussia, US, experts shared this sentiment while deliberating the existing challenges and the procedures that must be implemented to put patients at the true centre of clinical trial operations.
➡ Click here to read more: https://shorturl.at/G1pNb
➡Published by Clinical Trials Arena
![Clinical trial optimisation starts with the patient at the centre]()
Clinical trial optimisation starts with the patient at the centre
clinicaltrialsarena.com
Felix Perez, CEO Research Director
3moExciting news! Looking forward to seeing PSI's impact on Turkey's clinical trial landscape with your new office in Ankara. Here's to fostering innovation and advancing healthcare through strategic expansion!